Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452140
Status:
TERMINATED
Last Update Posted:
2009-05-19
First Post:
2007-03-26
Brief Title:
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
Sponsor:
Organization:
Neovii Biotech